Targeting macrophages in atherosclerosis using nanocarriers loaded with liver X receptor agonists: A narrow review
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Molecular Biosciences"
DOI: 10.3389/fmolb.2023.1147699
Abstract: Macrophages are involved in the whole process of atherosclerosis, which is characterized by accumulation of lipid and inflammation. Presently, clinically used lipid-lowering drugs cannot completely retard the progress of atherosclerosis. Liver X receptor (LXR) plays… read more here.
Keywords: lxr agonists; macrophages atherosclerosis; nanocarriers loaded; atherosclerosis ... See more keywords